chr7:100770385:> Detail (hg19)
Information
Genome
Assembly | Position |
---|---|
hg19 | chr7:100,770,385-100,782,528 |
hg38 | chr7:101,127,104-101,139,247 |
HGVS
Type | Transcript | Protein |
---|---|---|
Summary
MGeND
Clinical significance | |
Variant entry | |
GWAS entry | |
Disease area statistics | Show details |
Frequency
[No Data.]
Prediction
[No Data.]
ClinVar
Clinical Significance | |
Review star | [No Data.] |
Show details |
Links
Disease area statistics
[No Data.]
MGeND
[No Data.]
ClinVar
[No Data.]
CIViC
[No Data.]
DisGeNET
Score | Disease name | Description | Source | Pubmed | Links |
---|---|---|---|---|---|
0.004 | squamous cell carcinoma | NA | BeFree,LHGDN | Detail | |
<0.001 | Cardiomyopathy, Dilated | NA | BeFree | Detail | |
0.049 | Cardiovascular Diseases | This review provides an overview on the current knowledge on PAI-1 especially im... | BeFree,GAD,LHGDN | 25386620 | Detail |
0.002 | carotid stenosis | NA | GAD | Detail | |
0.003 | intracranial aneurysm | NA | BeFree,GAD | Detail | |
0.002 | Cerebral Arterial Diseases | NA | GAD | Detail | |
0.006 | cerebral infarction | NA | BeFree,GAD | Detail | |
0.009 | brain ischemia | NA | GAD | Detail | |
0.007 | cerebral palsy | NA | GAD | Detail | |
0.002 | Cerebrovascular Disorders | NA | GAD | Detail | |
0.001 | Malignant tumor of cervix | NA | BeFree | Detail | |
0.120 | cholestasis | NA | CTD_human | Detail | |
0.002 | chorioamnionitis | NA | GAD | Detail | |
<0.001 | colitis | NA | BeFree | Detail | |
0.003 | Colonic Neoplasms | NA | BeFree,LHGDN | Detail | |
0.004 | colorectal carcinoma | Furthermore, unlike CEA and PAI-1, up-regulation of TRFM in pathological stages ... | BeFree | 25216327 | Detail |
0.004 | colorectal carcinoma | Silencing of plasminogen activator inhibitor-1 suppresses colorectal cancer prog... | BeFree | 26275833 | Detail |
0.003 | Colorectal Neoplasms | NA | LHGDN | Detail | |
<0.001 | allergic conjunctivitis | NA | BeFree | Detail | |
0.002 | Connective Tissue Diseases | NA | GAD | Detail | |
0.003 | coronary aneurysm | NA | LHGDN | Detail | |
0.031 | Coronary Arteriosclerosis | NA | BeFree,GAD | Detail | |
0.020 | Coronary heart disease | NA | BeFree,GAD,LHGDN | Detail | |
<0.001 | coronary thrombosis | NA | BeFree | Detail | |
0.005 | Crohn Disease | NA | BeFree,GAD | Detail | |
<0.001 | cystic fibrosis | NA | BeFree | Detail | |
<0.001 | cystitis | NA | BeFree | Detail | |
0.002 | Hearing Loss, Sudden | NA | GAD | Detail | |
<0.001 | Presenile dementia | Our results show that plasma PAI-1 levels gradually increased as dementia progre... | BeFree | 25304332 | Detail |
0.003 | Mental Depression | Using data from the borderline subscale of the Personality Assessment Inventory ... | BeFree,GAD | 23979607 | Detail |
<0.001 | depressive disorder | Using data from the borderline subscale of the Personality Assessment Inventory ... | BeFree | 23979607 | Detail |
<0.001 | scleroderma | NA | BeFree | Detail | |
0.008 | Diabetes | Role of plasminogen activator inhibitor-1 in glucocorticoid-induced diabetes and... | BeFree,GAD | 25552599 | Detail |
0.014 | diabetes mellitus | Role of plasminogen activator inhibitor-1 in glucocorticoid-induced diabetes and... | BeFree,GAD | 25552599 | Detail |
0.120 | Diabetes Mellitus, Experimental | NA | CTD_human | Detail | |
<0.001 | Diabetes Mellitus, Insulin-Dependent | NA | BeFree | Detail | |
0.120 | Diabetes Mellitus, Non-Insulin-Dependent | Patients with type 2 diabetes showed increased expression of PAI-1, indicative o... | BeFree,GAD,RGD | 25496999 | Detail |
<0.001 | Diabetic Angiopathies | NA | BeFree | Detail | |
0.203 | Diabetic Nephropathy | NA | BeFree,CTD_human,RGD | Detail | |
0.007 | diabetic retinopathy | NA | BeFree,GAD,LHGDN | Detail | |
0.005 | disseminated intravascular coagulation | NA | BeFree,GAD,LHGDN | Detail | |
<0.001 | duodenal ulcer | NA | BeFree | Detail | |
<0.001 | Dyspepsia | NA | BeFree | Detail | |
0.002 | eclampsia | NA | BeFree | Detail | |
0.002 | Pathological accumulation of air in tissues | NA | GAD | Detail | |
0.012 | endometriosis | NA | BeFree,GAD,LHGDN | Detail | |
<0.001 | Enteritis | NA | BeFree | Detail | |
0.123 | Fatty Liver | NA | BeFree,CTD_human,LHGDN | Detail | |
0.002 | Fetal Diseases | NA | GAD | Detail | |
0.002 | Fetal Membranes, Premature Rupture | NA | GAD | Detail | |
0.002 | fibromyalgia | NA | GAD | Detail | |
<0.001 | fibrosarcoma | NA | BeFree | Detail | |
0.008 | Fibrosis | NA | LHGDN | Detail | |
<0.001 | gastritis | NA | BeFree | Detail | |
<0.001 | Gastrointestinal Neoplasms | NA | BeFree | Detail | |
0.002 | generalized atherosclerosis | NA | GAD | Detail | |
0.005 | Glaucoma, Open-Angle | NA | GAD,LHGDN | Detail | |
0.004 | glioblastoma | NA | BeFree,LHGDN | Detail | |
0.008 | Glioma | NA | BeFree,LHGDN | Detail | |
0.003 | glomerulonephritis | NA | BeFree,LHGDN | Detail | |
0.123 | IgA glomerulonephritis | Association between plasminogen activator inhibitor-1 4G/5G gene polymorphism an... | BeFree,CTD_human,GAD | 24918969 | Detail |
0.003 | membranous glomerulonephritis | NA | BeFree,LHGDN | Detail | |
0.120 | Focal glomerulosclerosis | NA | CTD_human | Detail | |
0.002 | Graft Occlusion, Vascular | NA | GAD | Detail | |
0.002 | Hay fever | NA | GAD | Detail | |
<0.001 | cardiac arrest | NA | BeFree | Detail | |
0.005 | Heart Diseases | NA | BeFree,GAD | Detail | |
0.120 | Heart failure | NA | BeFree,CTD_human | Detail | |
<0.001 | Myocardial rupture | NA | BeFree | Detail | |
<0.001 | Hemangioendothelioma | Penile pseudomyogenic hemangioendothelioma/epithelioid sarcoma-like hemangioendo... | BeFree | 25749627 | Detail |
<0.001 | Hemangiosarcoma | NA | BeFree | Detail | |
0.002 | hemolytic-uremic syndrome | NA | GAD | Detail | |
0.003 | Hemophilia A | NA | BeFree,GAD | Detail | |
0.002 | Hemorrhagic Disorders | NA | GAD | Detail | |
<0.001 | Hemorrhagic Fever with Renal Syndrome | NA | BeFree | Detail | |
<0.001 | Hepatic Vein Thrombosis | NA | BeFree | Detail | |
<0.001 | hepatitis B | In conclusion, thrombo and fibro-genetic mechanisms of PAI-1 4G-4G and MTHFR 677... | BeFree | 25987440 | Detail |
0.002 | hepatitis C | NA | GAD | Detail | |
<0.001 | HIV Infections | NA | BeFree | Detail | |
<0.001 | Hodgkin Disease | NA | BeFree | Detail | |
<0.001 | Huntington disease | NA | BeFree | Detail | |
0.006 | Hypercholesterolemia | NA | BeFree,GAD,LHGDN | Detail | |
0.001 | Hypercholesterolemia, Familial | NA | BeFree | Detail | |
0.001 | hyperglycemia | NA | BeFree | Detail | |
0.002 | hyperinsulinism | PAI-1 polymorphism was synergistic with hyperinsulinemia. | BeFree | 25205258 | Detail |
0.001 | Hyperlipidemia | PAI-1 deficiency significantly reduced insulin resistance and glucose intoleranc... | BeFree | 25552599 | Detail |
0.003 | Hyperlipidemia, Familial Combined | NA | BeFree,LHGDN | Detail | |
0.003 | Hyperplasia | NA | LHGDN | Detail | |
0.002 | Immediate hypersensitivity | NA | GAD | Detail | |
0.175 | Hypertensive disease | Hypertension is associated with increased expression of FABP3, FAS, FN1, IL1R2, ... | BeFree,CTD_human,GAD,LHGDN | 23337395 | Detail |
0.175 | Hypertensive disease | The presence of type 2 diabetes associated with 3.2-fold increased PAI-1 express... | BeFree,CTD_human,GAD,LHGDN | 25496999 | Detail |
0.003 | hyperthyroidism | NA | LHGDN | Detail | |
0.003 | Hypertriglyceridemia | NA | LHGDN | Detail | |
<0.001 | Ileal Diseases | NA | BeFree | Detail | |
<0.001 | Immunologic Deficiency Syndromes | NA | BeFree | Detail | |
0.002 | infertility | NA | GAD | Detail | |
0.005 | Female infertility | NA | GAD | Detail | |
0.015 | Inflammation | NA | GAD,LHGDN | Detail | |
0.003 | Inflammatory Bowel Diseases | NA | BeFree,GAD | Detail | |
<0.001 | influenza | Plasminogen activator inhibitor-1 in cigarette smoke exposure and influenza A vi... | BeFree | 25932922 | Detail |
0.082 | Insulin resistance | NA | GAD,RGD | Detail | |
<0.001 | intermittent claudication | NA | BeFree | Detail | |
<0.001 | Intestinal Diseases | NA | BeFree | Detail | |
<0.001 | ischemia | NA | BeFree | Detail | |
0.003 | Keloid | Association of the plasminogen activator inhibitor-1 (PAI-1) Gene -675 4G/5G and... | BeFree | 25350781 | Detail |
<0.001 | Keratoconjunctivitis, Vernal | NA | BeFree | Detail | |
0.009 | Kidney Diseases | NA | BeFree,GAD | Detail | |
0.128 | Kidney Failure, Chronic | NA | BeFree,CTD_human,GAD | Detail | |
<0.001 | acute kidney tubular necrosis | NA | BeFree | Detail | |
<0.001 | Klinefelter syndrome | NA | BeFree | Detail | |
0.002 | Premature Obstetric Labor | NA | GAD | Detail | |
<0.001 | Leg Ulcer | NA | BeFree | Detail | |
<0.001 | Fibroid Tumor | NA | BeFree | Detail | |
<0.001 | leiomyosarcoma | NA | BeFree | Detail | |
0.003 | lymphoid leukemia | NA | LHGDN | Detail | |
<0.001 | Acute lymphocytic leukemia | NA | BeFree | Detail | |
<0.001 | lipodystrophy | NA | BeFree | Detail | |
0.010 | liver cirrhosis | In conclusion, thrombo and fibro-genetic mechanisms of PAI-1 4G-4G and MTHFR 677... | BeFree,GAD,LHGDN | 25987440 | Detail |
0.002 | Liver Cirrhosis, Alcoholic | NA | GAD | Detail | |
0.002 | Liver diseases | NA | GAD | Detail | |
0.122 | Liver neoplasms | NA | BeFree,CTD_human | Detail | |
<0.001 | Lung diseases | NA | BeFree | Detail | |
0.090 | Chronic Obstructive Airway Disease | We found increased p53, PAI-1 and apoptosis in AECs, with accumulation of macrop... | BeFree,GAD,RGD | 25932922 | Detail |
<0.001 | Lupus Vulgaris | NA | BeFree | Detail | |
<0.001 | Lupus Erythematosus, Discoid | NA | BeFree | Detail | |
0.008 | Lupus Erythematosus, Systemic | NA | BeFree,GAD | Detail | |
0.011 | lupus nephritis | NA | BeFree,GAD,LHGDN | Detail | |
<0.001 | Lymphatic Metastasis | Plasma PAI-1 level was higher in CRC patients with liver metastasis and correlat... | BeFree | 26275833 | Detail |
0.005 | Malignant neoplasm of stomach | miR-30b may function as a novel tumor suppressor gene in gastric cancer by targe... | BeFree | 25170877 | Detail |
0.004 | melanoma | NA | BeFree,LHGDN | Detail | |
<0.001 | meningioma | NA | BeFree | Detail | |
<0.001 | meningitis | NA | BeFree | Detail | |
<0.001 | Meningitis, Pneumococcal | NA | BeFree | Detail | |
0.019 | Meningococcal Infections | NA | BeFree,GAD,LHGDN | Detail | |
0.001 | Meningococcemia | NA | BeFree | Detail | |
<0.001 | Mesothelioma | NA | BeFree | Detail | |
0.002 | Metabolic Diseases | NA | BeFree | Detail | |
<0.001 | Mucocutaneous Lymph Node Syndrome | NA | BeFree | Detail | |
0.001 | multiple myeloma | NA | BeFree | Detail | |
0.005 | Multiple Organ Failure | NA | GAD,LHGDN | Detail | |
0.006 | multiple sclerosis | NA | BeFree,GAD,LHGDN | Detail | |
0.080 | muscular atrophy | In conclusion, the current study indicated that PAI-1 is involved in GC-induced ... | BeFree,RGD | 25552599 | Detail |
<0.001 | muscular dystrophy | NA | BeFree | Detail | |
0.002 | Musculoskeletal Diseases | NA | GAD | Detail | |
<0.001 | Myeloproliferative disease | Elevated levels of PAI-1 in MPN patients may result from its increased productio... | BeFree | 24509338 | Detail |
0.173 | myocardial infarction | The association between plasminogen activator inhibitor type 1 (PAI-1) levels, P... | BeFree,GAD,LHGDN,RGD | 24695040 | Detail |
0.173 | myocardial infarction | We aimed to investigate the association of plasminogen activator inhibitor-1 (PA... | BeFree,GAD,LHGDN,RGD | 25113642 | Detail |
0.173 | myocardial infarction | PAI-1 plays a pivotal role in acute thrombotic events such as deep vein thrombos... | BeFree,GAD,LHGDN,RGD | 25386620 | Detail |
<0.001 | myoma | NA | BeFree | Detail | |
0.002 | Neoplasm Invasiveness | NA | GAD | Detail | |
0.020 | Neoplasm Metastasis | NA | BeFree,LHGDN | Detail | |
0.002 | Neoplasm Recurrence, Local | NA | GAD | Detail | |
<0.001 | nephritis | NA | BeFree | Detail | |
0.121 | nephrotic syndrome | NA | BeFree,CTD_human | Detail | |
0.120 | nervous system disorder | NA | CTD_human | Detail | |
<0.001 | neuroblastoma | NA | BeFree | Detail | |
0.002 | Fibrosis, Liver | The aim of this work was to establish an association between the single-nucleoti... | BeFree | 23941979 | Detail |
0.001 | Virus Diseases | The aim of this work was to establish an association between the single-nucleoti... | BeFree | 23941979 | Detail |
0.164 | obesity | NA | BeFree,CTD_human,GAD | Detail | |
<0.001 | Obesity, Morbid | NA | BeFree | Detail | |
<0.001 | oral submucous fibrosis | NA | BeFree | Detail | |
0.003 | Degenerative polyarthritis | NA | BeFree,LHGDN | Detail | |
<0.001 | Osteoarthropathy, Primary Hypertrophic | NA | BeFree | Detail | |
<0.001 | osteomyelitis | NA | BeFree | Detail | |
0.013 | Bone necrosis | NA | GAD,LHGDN | Detail | |
<0.001 | Osteoporosis, Postmenopausal | NA | BeFree | Detail | |
<0.001 | Ear Inflammation | NA | BeFree | Detail | |
0.003 | otitis media | NA | BeFree,LHGDN | Detail | |
0.004 | ovarian carcinoma | Inhibition of plasminogen activator inhibitor-1 is a potential therapeutic strat... | BeFree | 25587663 | Detail |
0.004 | ovarian carcinoma | P21, GADD45 and PAI-1 expression were down-regulated in mutant OCCs. | BeFree | 25958320 | Detail |
0.002 | Ovarian Diseases | NA | BeFree | Detail | |
0.003 | Pancreatic Neoplasm | NA | LHGDN | Detail | |
0.002 | pancreatitis | NA | GAD | Detail | |
<0.001 | Peyronie Disease | NA | BeFree | Detail | |
<0.001 | Peptic Ulcer | NA | BeFree | Detail | |
0.003 | familial Mediterranean fever | NA | BeFree,GAD | Detail | |
0.003 | Periodontal Diseases | NA | BeFree,LHGDN | Detail | |
0.006 | periodontitis | NA | BeFree,GAD | Detail | |
<0.001 | peritonitis | NA | BeFree | Detail | |
<0.001 | pheochromocytoma | NA | BeFree | Detail | |
0.002 | Placenta Disorders | NA | GAD | Detail | |
<0.001 | placental insufficiency | The 4G/4G polymorphism of the plasminogen activator inhibitor-1 (PAI-1) gene as ... | BeFree | 25723084 | Detail |
0.002 | Pneumococcal Infections | NA | GAD | Detail | |
0.002 | pneumoconiosis | NA | GAD | Detail | |
0.014 | pneumonia | These observations indicate that increased PAI-1 expression promotes AEC apoptos... | BeFree,GAD,LHGDN | 25932922 | Detail |
<0.001 | Lobar Pneumonia | NA | BeFree | Detail | |
0.047 | polycystic ovary syndrome | 4G/5G polymorphism of plasminogen activator inhibitor-1 gene is associated with ... | BeFree,GAD,LHGDN | 25731152 | Detail |
<0.001 | polycythemia vera | Concentration of PAI-1:Ag was increased in patients with essential thrombocythem... | BeFree | 24509338 | Detail |
0.003 | Adenomatous Polyposis Coli | NA | BeFree,LHGDN | Detail | |
<0.001 | Polyuria | NA | BeFree | Detail | |
0.005 | Postoperative Complications | NA | GAD | Detail | |
0.005 | Postoperative Hemorrhage | NA | GAD | Detail | |
0.145 | pre-eclampsia | NA | CTD_human,GAD,LHGDN | Detail | |
<0.001 | Pregnancy Complications | Hereditary hypofibrinolysis, which is mediated by 4G/4G homozygosity for the PAI... | BeFree | 25723084 | Detail |
0.002 | Pregnancy Complications, Cardiovascular | NA | GAD | Detail | |
0.005 | Pregnancy Complications, Hematologic | NA | GAD | Detail | |
0.123 | Prostatic Neoplasms | NA | BeFree,CTD_human,LHGDN | Detail | |
0.002 | Puerperal Disorders | NA | GAD | Detail | |
<0.001 | pulmonary edema | NA | BeFree | Detail | |
0.008 | pulmonary embolism | NA | BeFree,GAD | Detail | |
<0.001 | pulmonary emphysema | NA | BeFree | Detail | |
0.082 | pulmonary fibrosis | The biological effects of PAI-1 extend far beyond thrombosis including its criti... | BeFree,RGD | 25386620 | Detail |
<0.001 | pyelonephritis | NA | BeFree | Detail | |
<0.001 | kidney failure | NA | BeFree | Detail | |
0.006 | Respiratory Distress Syndrome, Adult | NA | BeFree,GAD,LHGDN | Detail | |
0.120 | Respiratory Hypersensitivity | NA | CTD_human | Detail | |
0.002 | retinal artery occlusion | NA | GAD | Detail | |
0.002 | Retinal Diseases | NA | BeFree | Detail | |
0.005 | retinal vascular occlusion | NA | GAD | Detail | |
0.003 | retinal vein occlusion | In our study, the FII G20210A and the MTHFR C677T mutations resulted significant... | BeFree,GAD | 24569626 | Detail |
<0.001 | rhabdomyosarcoma | NA | BeFree | Detail | |
0.002 | Rhinitis, Allergic, Perennial | NA | GAD | Detail | |
<0.001 | systemic scleroderma | Expression levels of other TGF-β-regulated genes, including SERPINE1 and CTGF, d... | BeFree | 26098215 | Detail |
<0.001 | Seizures | NA | BeFree | Detail | |
<0.001 | seminoma | NA | BeFree | Detail | |
<0.001 | Age-related cataract | NA | BeFree | Detail | |
0.002 | Septicemia | NA | BeFree | Detail | |
0.002 | Septic Shock | NA | GAD | Detail | |
0.003 | sinusitis | NA | BeFree,GAD | Detail | |
<0.001 | Skin Abnormalities | NA | BeFree | Detail | |
0.002 | Dermatologic disorders | NA | GAD | Detail | |
<0.001 | Soft Tissue Neoplasms | NA | BeFree | Detail | |
<0.001 | Stomach Diseases | NA | BeFree | Detail | |
0.128 | Stomach Neoplasms | NA | BeFree,CTD_human,GAD,LHGDN | Detail | |
0.003 | gastric ulcer | NA | BeFree,GAD | Detail | |
0.002 | Streptococcal Infections | NA | GAD | Detail | |
<0.001 | Stress, Psychological | NA | BeFree | Detail | |
0.063 | Cerebrovascular accident | Pai-1 gene variants and COC use are associated with stroke risk: a case-control ... | BeFree,GAD,LHGDN | 25231632 | Detail |
0.007 | Subarachnoid Hemorrhage | NA | BeFree,GAD | Detail | |
<0.001 | synovitis | NA | BeFree | Detail | |
0.002 | Testicular Neoplasms | NA | GAD | Detail | |
<0.001 | Thrombocythemia, Essential | Concentration of PAI-1:Ag was increased in patients with essential thrombocythem... | BeFree | 24509338 | Detail |
0.004 | Thromboembolism | Association between the plasminogen activator inhibitor-1 4G/5G polymorphism and... | BeFree | 25450536 | Detail |
0.174 | thrombosis | NA | CTD_human,GAD,LHGDN | Detail | |
<0.001 | Turner syndrome | NA | BeFree | Detail | |
<0.001 | Unipolar Depression | NA | BeFree | Detail | |
0.080 | ureteral obstruction | ATM activation (pATM(Ser1981)) increased 4-fold in the tubulointerstitial region... | BeFree,RGD | 25480384 | Detail |
0.002 | Uterine Diseases | NA | GAD | Detail | |
<0.001 | Uterine Fibroids | NA | BeFree | Detail | |
0.018 | Vascular Diseases | The inactivation of plasminogen activator inhibitor-1 (PAI-1) has been shown to ... | BeFree,GAD,LHGDN | 25040736 | Detail |
0.002 | venous insufficiency | NA | GAD | Detail | |
0.102 | Venous Thrombosis | NA | GAD,LHGDN,RGD | Detail | |
0.002 | Virilism | NA | GAD | Detail | |
0.001 | Virus Diseases | Plasminogen activator inhibitor-1 in cigarette smoke exposure and influenza A vi... | BeFree | 25932922 | Detail |
0.001 | Werner syndrome | NA | BeFree | Detail | |
<0.001 | Yersinia infections | NA | BeFree | Detail | |
0.003 | Cerebral Thrombosis | NA | BeFree,GAD | Detail | |
0.008 | Fibromatosis, Aggressive | NA | BeFree,GAD,LHGDN | Detail | |
<0.001 | Ichthyosis, X-Linked | NA | BeFree | Detail | |
0.003 | Bronchial Hyperreactivity | NA | BeFree,GAD | Detail | |
0.003 | gestational diabetes | NA | BeFree,GAD | Detail | |
<0.001 | Ovarian Failure, Premature | NA | BeFree | Detail | |
0.008 | antiphospholipid syndrome | NA | BeFree,GAD | Detail | |
0.002 | Sudden cardiac death | NA | GAD | Detail | |
0.001 | Polyendocrinopathies, Autoimmune | NA | BeFree | Detail | |
0.001 | essential hypertension | NA | BeFree | Detail | |
<0.001 | Encephalopathies | NA | BeFree | Detail | |
0.003 | Liver failure | NA | LHGDN | Detail | |
<0.001 | Hamman-Rich syndrome | NA | BeFree | Detail | |
<0.001 | Idiopathic Membranous Glomerulonephritis | NA | BeFree | Detail | |
<0.001 | cataract | NA | BeFree | Detail | |
<0.001 | benign neoplasm | NA | BeFree | Detail | |
<0.001 | Left Ventricular Hypertrophy | NA | BeFree | Detail | |
<0.001 | Sepsis due to urinary tract infection | NA | BeFree | Detail | |
0.014 | Deep Vein Thrombosis | PAI-1 4G/5G and MTHFR C677T polymorphisms increased the accuracy of two predicti... | BeFree,GAD | 24715181 | Detail |
0.014 | Deep Vein Thrombosis | PAI-1 plays a pivotal role in acute thrombotic events such as deep vein thrombos... | BeFree,GAD | 25386620 | Detail |
<0.001 | Small cell carcinoma of lung | NA | BeFree | Detail | |
<0.001 | obstructive nephropathy | NA | BeFree | Detail | |
<0.001 | Adenocarcinoma of rectum | NA | BeFree | Detail | |
0.012 | Premature Birth | NA | GAD | Detail | |
<0.001 | Oral Cavity Carcinoma | NA | BeFree | Detail | |
<0.001 | renal fibrosis | NA | BeFree | Detail | |
0.012 | Myocardial Ischemia | NA | BeFree,GAD | Detail | |
0.002 | Abnormal renal function | NA | GAD | Detail | |
0.003 | Arterial thrombosis | NA | BeFree | Detail | |
<0.001 | Thrombosis of cerebral veins | NA | BeFree | Detail | |
0.001 | Deep thrombophlebitis | NA | BeFree | Detail | |
<0.001 | Idiopathic pulmonary hypertension | NA | BeFree | Detail | |
<0.001 | Chronic glomerulonephritis | NA | BeFree | Detail | |
0.003 | Malignant neoplasm of mouth | NA | BeFree,GAD | Detail | |
<0.001 | Malignant neoplasm of testis | NA | BeFree | Detail | |
<0.001 | Secondary malignant neoplasm of lung | NA | BeFree | Detail | |
<0.001 | Secondary malignant neoplasm of bone | NA | BeFree | Detail | |
<0.001 | proliferative diabetic retinopathy | NA | BeFree | Detail | |
<0.001 | central retinal vein occlusion | NA | BeFree | Detail | |
0.003 | acute myocardial infarction | Relation of PAI-1 and TPA genes polymorphisms to acute myocardial infarction and... | BeFree | 25113642 | Detail |
<0.001 | Old myocardial infarction | NA | BeFree | Detail | |
<0.001 | portal vein thrombosis | In conclusion, thrombo and fibro-genetic mechanisms of PAI-1 4G-4G and MTHFR 677... | BeFree | 25987440 | Detail |
<0.001 | Streptococcal pneumonia | NA | BeFree | Detail | |
0.001 | allergic asthma | NA | BeFree | Detail | |
<0.001 | Peritoneal adhesion | NA | BeFree | Detail | |
<0.001 | retinal ischemia | NA | BeFree | Detail | |
<0.001 | adrenoleukodystrophy | NA | BeFree | Detail | |
0.003 | Colitis, Ischemic | NA | BeFree,GAD | Detail | |
<0.001 | Cicatrix, Hypertrophic | MiR-10a and miR-181c regulate collagen type I generation in hypertrophic scars b... | BeFree | 25554417 | Detail |
0.005 | Aneurysm, Ruptured | NA | GAD | Detail | |
0.091 | Aortic Aneurysm, Abdominal | NA | BeFree,GAD,RGD | Detail | |
<0.001 | Aortic Aneurysm, Thoracic | NA | BeFree | Detail | |
0.002 | Glomerulosclerosis (disorder) | NA | BeFree | Detail | |
0.003 | Tumor Progression | NA | BeFree | Detail | |
<0.001 | histiocytoid hemangioma | Although FOSB-rearranged EH do not show significant morphologic overlap with SER... | BeFree | 25043949 | Detail |
0.002 | Community-Acquired Infections | NA | GAD | Detail | |
<0.001 | hepatoblastoma | NA | BeFree | Detail | |
<0.001 | Adenocarcinoma, Clear Cell | Interestingly, expression of PAI-1 was increased in ovarian clear cell carcinoma... | BeFree | 25587663 | Detail |
<0.001 | Follicular thyroid carcinoma | NA | BeFree | Detail | |
<0.001 | uveal melanoma | NA | BeFree | Detail | |
<0.001 | Lip and oral cavity carcinoma | NA | BeFree | Detail | |
0.005 | alpha 1-antitrypsin deficiency | NA | GAD | Detail | |
<0.001 | Premature aging syndrome | NA | BeFree | Detail | |
<0.001 | pancreatic carcinoma | NA | BeFree | Detail | |
<0.001 | Renal interstitial fibrosis | NA | BeFree | Detail | |
<0.001 | Thrombosis of renal vein | NA | BeFree | Detail | |
<0.001 | Papillary thyroid carcinoma | NA | BeFree | Detail | |
0.002 | Fibrosis, Liver | NA | BeFree | Detail | |
<0.001 | Interstitial fibrosis | NA | BeFree | Detail | |
0.006 | coronary stenosis | NA | BeFree,GAD,LHGDN | Detail | |
0.009 | Dyslipidemias | NA | BeFree,GAD,LHGDN | Detail | |
0.007 | Malignant neoplasm of lung | Plasminogen activator inhibitor-1 and susceptibility to lung cancer: a populatio... | BeFree,GAD | 24955483 | Detail |
<0.001 | age related macular degeneration | NA | BeFree | Detail | |
0.002 | Acute Lung Injury | NA | GAD | Detail | |
0.002 | Oxidative Stress | NA | GAD | Detail | |
<0.001 | protein S deficiency | NA | BeFree | Detail | |
<0.001 | Systemic Inflammatory Response Syndrome | NA | BeFree | Detail | |
0.019 | Sepsis | NA | BeFree,GAD,LHGDN | Detail | |
<0.001 | subendocardial myocardial infarction | NA | BeFree | Detail | |
<0.001 | Coronary artery atheroma | NA | BeFree | Detail | |
0.003 | Chronic Periodontitis | NA | BeFree,LHGDN | Detail | |
0.080 | Pancreatitis, Acute Necrotizing | NA | BeFree,RGD | Detail | |
<0.001 | 5,10-Methylenetetrahydrofolate reductase deficiency | NA | BeFree | Detail | |
<0.001 | Renal glomerular disease | NA | BeFree | Detail | |
<0.001 | Endometrioma | NA | BeFree | Detail | |
<0.001 | Atopic cataract | NA | BeFree | Detail | |
<0.001 | Acute otitis media | NA | BeFree | Detail | |
<0.001 | Impaired glucose tolerance | PAI-1 deficiency significantly reduced insulin resistance and glucose intoleranc... | BeFree | 25552599 | Detail |
<0.001 | Cancer of Head and Neck | NA | BeFree | Detail | |
<0.001 | Conventional (Clear Cell) Renal Cell Carcinoma | NA | BeFree | Detail | |
<0.001 | Solid tumour | NA | BeFree | Detail | |
<0.001 | Adenocarcinoma of pancreas | NA | BeFree | Detail | |
0.001 | cervix carcinoma | NA | BeFree | Detail | |
0.001 | Obesity, Abdominal | NA | BeFree | Detail | |
<0.001 | Lupus anticoagulant disorder | NA | BeFree | Detail | |
<0.001 | Fibrous nodule | NA | BeFree | Detail | |
0.003 | Restenosis | NA | BeFree,GAD | Detail | |
<0.001 | Mural thrombus | NA | BeFree | Detail | |
<0.001 | Platelet thrombus | NA | BeFree | Detail | |
<0.001 | Senile Plaques | In contrary, PAI-1 expression increases during aging or Aβ deposition with its c... | BeFree | 25454795 | Detail |
<0.001 | Tumor necrosis | NA | BeFree | Detail | |
<0.001 | anaplastic astrocytoma | NA | BeFree | Detail | |
<0.001 | Proliferative retinopathy | NA | BeFree | Detail | |
<0.001 | Anterior myocardial infarction | NA | BeFree | Detail | |
<0.001 | Aortic aneurysm without mention of rupture NOS | NA | BeFree | Detail | |
<0.001 | Dissection of aorta | NA | BeFree | Detail | |
0.003 | Deep vein thrombosis of lower limb | PAI-1 4G/5G and MTHFR C677T polymorphisms increased the accuracy of two predicti... | BeFree | 24715181 | Detail |
<0.001 | Venous hypertension | NA | BeFree | Detail | |
0.002 | Complications of Diabetes Mellitus | NA | GAD | Detail | |
<0.001 | Deficiency of testosterone biosynthesis | NA | BeFree | Detail | |
<0.001 | Precocious pubarche | NA | BeFree | Detail | |
<0.001 | Organ dysfunction syndrome | NA | BeFree | Detail | |
<0.001 | malignant mesothelioma | NA | BeFree | Detail | |
<0.001 | Malignant neoplasm of pancreas | NA | BeFree | Detail | |
<0.001 | Asthma attack | NA | BeFree | Detail | |
<0.001 | Pulmonary lymphangioleiomyomatosis | NA | BeFree | Detail | |
<0.001 | Ischemic cardiomyopathy | NA | BeFree | Detail | |
0.001 | Helicobacter pylori (H. pylori) infection in conditions classified elsewhere and of unspecified site | NA | BeFree | Detail | |
0.007 | Malignant neoplasm of prostate | NA | BeFree,GAD | Detail | |
0.080 | Endotoxemia | NA | RGD | Detail | |
<0.001 | Recurrent acute otitis media | NA | BeFree | Detail | |
0.023 | thrombophilia | NA | BeFree,GAD,LHGDN | Detail | |
<0.001 | Non-alcoholic Fatty Liver Disease | Animal models of non-alcoholic fatty liver disease (NAFLD) suggest that an incre... | BeFree | 24351080 | Detail |
<0.001 | Idiopathic crescentic glomerulonephritis | NA | BeFree | Detail | |
0.003 | Chronic Kidney Insufficiency | NA | BeFree,GAD | Detail | |
0.003 | Osteoarthritis, Knee | NA | LHGDN | Detail | |
<0.001 | lupus erythematosus | NA | BeFree | Detail | |
<0.001 | Klinefelter's syndrome - male with more than two X chromosomes | NA | BeFree | Detail | |
<0.001 | Non-obstructive reflux-associated chronic pyelonephritis (disorder) | NA | BeFree | Detail | |
0.001 | endometrial carcinoma | NA | BeFree | Detail | |
<0.001 | pricking of skin | NA | BeFree | Detail | |
0.001 | Secondary malignant neoplasm of liver | Silencing of plasminogen activator inhibitor-1 suppresses colorectal cancer prog... | BeFree | 26275833 | Detail |
<0.001 | dementia | Our results show that plasma PAI-1 levels gradually increased as dementia progre... | BeFree | 25304332 | Detail |
<0.001 | Overweight | NA | BeFree | Detail | |
<0.001 | acute pyelonephritis | NA | BeFree | Detail | |
0.003 | Sleep Apnea, Obstructive | NA | BeFree,GAD | Detail | |
<0.001 | Bilateral cataracts (disorder) | NA | BeFree | Detail | |
<0.001 | Associated symptom | NA | BeFree | Detail | |
0.016 | Metabolic syndrome X | The current study tried to investigate in parallel the association of PAI-1 acti... | BeFree,GAD | 24695040 | Detail |
0.003 | Pulmonary Thromboembolisms | NA | BeFree,GAD | Detail | |
<0.001 | Atherosclerotic occlusive disease | NA | BeFree | Detail | |
0.002 | Brain hemorrhage | NA | GAD | Detail | |
0.002 | Menopause present (finding) | NA | GAD | Detail | |
0.004 | Factor V Leiden mutation | The polymorphisms of FVL and FII should be screened in RM women, whereas PAI-1 s... | BeFree | 24484533 | Detail |
0.004 | Factor V Leiden mutation | In terms of subgroup analyses on co-existence of other thrombotic risk factors, ... | BeFree | 25450536 | Detail |
0.002 | Carcinogenesis | NA | BeFree | Detail | |
<0.001 | hyperhomocysteinemia | NA | BeFree | Detail | |
0.002 | prostate carcinoma | NA | BeFree | Detail | |
0.001 | Activated Protein C Resistance | NA | BeFree | Detail | |
0.005 | hepatopulmonary syndrome | NA | BeFree,GAD,LHGDN | Detail | |
0.001 | Epithelial ovarian cancer | P21, GADD45 and PAI-1 expression were down-regulated in mutant OCCs. | BeFree | 25958320 | Detail |
0.012 | breast carcinoma | NA | BeFree | Detail | |
0.002 | Carcinoma of lung | Plasminogen activator inhibitor-1 and susceptibility to lung cancer: a populatio... | BeFree | 24955483 | Detail |
0.002 | Secondary malignant neoplasm of lymph node | NA | BeFree | Detail | |
0.014 | Pregnancy loss | NA | GAD | Detail | |
<0.001 | Community acquired pneumonia | NA | BeFree | Detail | |
<0.001 | Infection of ear | NA | BeFree | Detail | |
0.002 | colon carcinoma | The biologic consequences of PAI-1 silencing in colon cancer cell lines and CRC ... | BeFree | 26275833 | Detail |
0.005 | stomach carcinoma | miR-30b may function as a novel tumor suppressor gene in gastric cancer by targe... | BeFree | 25170877 | Detail |
<0.001 | Carcinoma of bladder | NA | BeFree | Detail | |
<0.001 | skin carcinoma | NA | BeFree | Detail | |
<0.001 | Central neuroblastoma | NA | BeFree | Detail | |
<0.001 | Dissecting aneurysm of the thoracic aorta | NA | BeFree | Detail | |
<0.001 | Central Serous Chorioretinopathy | The prevalence of 4G/5G polymorphism of plasminogen activator inhibitor-1 (PAI-1... | BeFree | 24446892 | Detail |
<0.001 | Middle Cerebral Artery Occlusion | NA | BeFree | Detail | |
0.080 | Infarction, Middle Cerebral Artery | NA | RGD | Detail | |
<0.001 | cardiac event | NA | BeFree | Detail | |
<0.001 | early pregnancy | NA | BeFree | Detail | |
<0.001 | Acute Cerebrovascular Accidents | NA | BeFree | Detail | |
<0.001 | Myasthenia Gravis, Autoimmune, Experimental | In an attempt to treat EAMG with an 18aa peptide derived from the PA system inhi... | BeFree | 24423642 | Detail |
0.002 | intracranial embolism | NA | GAD | Detail | |
<0.001 | Dural Arteriovenous Fistula | NA | BeFree | Detail | |
<0.001 | Helicobacter pylori infection | NA | BeFree | Detail | |
0.009 | Pregnancy associated hypertension | NA | GAD | Detail | |
0.002 | Blood Coagulation Disorders, Inherited | NA | GAD | Detail | |
<0.001 | Arteriopathic disease | NA | BeFree | Detail | |
<0.001 | Invasive breast carcinoma | NA | BeFree | Detail | |
<0.001 | Testicular malignant germ cell tumor | NA | BeFree | Detail | |
0.002 | Endothelial dysfunction | NA | BeFree | Detail | |
0.003 | Budd-Chiari syndrome | NA | BeFree,LHGDN | Detail | |
<0.001 | Muscle fibrosis | NA | BeFree | Detail | |
<0.001 | Asthma chronic | NA | BeFree | Detail | |
<0.001 | Cerebral Ischemia | NA | BeFree | Detail | |
0.008 | ovarian neoplasm | NA | BeFree,LHGDN | Detail | |
<0.001 | Vascular inflammations | NA | BeFree | Detail | |
0.014 | Ischemic stroke | Plasminogen activator inhibitor-1 4G/5G polymorphism and ischemic stroke risk: a... | BeFree,GAD | 24472072 | Detail |
0.014 | Ischemic stroke | Global fibrinolytic activity, PAI-1 level, and 4G/5G polymorphism in Thai childr... | BeFree,GAD | 25284719 | Detail |
0.004 | Acute coronary syndrome | Healthy HDL inhibited thrombin-induced plasminogen activator inhibitor type 1 (P... | BeFree,GAD | 25056722 | Detail |
0.004 | Acute coronary syndrome | The -844 G>A PAI-1 polymorphism is associated with acute coronary syndrome in Me... | BeFree,GAD | 25788758 | Detail |
<0.001 | Venoocclusive disease | NA | BeFree | Detail | |
0.002 | coronary restenosis | NA | GAD | Detail | |
<0.001 | Macroangiopathy | NA | BeFree | Detail | |
0.001 | Vascular occlusion | NA | BeFree | Detail | |
0.003 | Invasive Ductal Breast Carcinoma | NA | BeFree,GAD | Detail | |
0.008 | Malignant neoplasm of ovary | Inhibition of plasminogen activator inhibitor-1 is a potential therapeutic strat... | BeFree,GAD | 25587663 | Detail |
0.003 | Ductal Carcinoma | NA | LHGDN | Detail | |
<0.001 | prothrombin gene mutation | NA | BeFree | Detail | |
<0.001 | Mural thrombus of heart | NA | BeFree | Detail | |
0.003 | sarcoma | NA | BeFree,LHGDN | Detail | |
<0.001 | attention deficit hyperactivity disorder | NA | BeFree | Detail | |
<0.001 | major depressive disorder | NA | BeFree | Detail | |
<0.001 | Mild cognitive disorder | The mean levels of plasma PAI-1 in patients with MCI and AD patients were signif... | BeFree | 25304332 | Detail |
<0.001 | First myocardial infarction | Three hundred and fifty six patients with first myocardial infarction (MI) were ... | BeFree | 23990179 | Detail |
<0.001 | nonspecific interstitial pneumonia | NA | BeFree | Detail | |
<0.001 | Chronic myeloproliferative disorder | Elevated levels of PAI-1 in MPN patients may result from its increased productio... | BeFree | 24509338 | Detail |
<0.001 | Peripheral arterial occlusive disease | NA | BeFree | Detail | |
<0.001 | Epithelioma | NA | BeFree | Detail | |
<0.001 | Conn Syndrome | NA | BeFree | Detail | |
<0.001 | Cardiomyopathy, Familial Idiopathic | NA | BeFree | Detail | |
0.036 | Mammary Neoplasms | NA | BeFree,GAD,LHGDN | Detail | |
<0.001 | Angiogenic Switch | We conclude that the HIF-2α target gene PAI-1 favors the angiogenic switch in HC... | BeFree | 25489981 | Detail |
<0.001 | Hepatocarcinogenesis | NA | BeFree | Detail | |
<0.001 | Tumor Angiogenesis | NA | BeFree | Detail | |
<0.001 | Xenograft Model | NA | BeFree | Detail | |
0.011 | colorectal cancer | Furthermore, unlike CEA and PAI-1, up-regulation of TRFM in pathological stages ... | BeFree,GAD | 25216327 | Detail |
0.011 | colorectal cancer | Silencing of plasminogen activator inhibitor-1 suppresses colorectal cancer prog... | BeFree,GAD | 26275833 | Detail |
<0.001 | brain edema | NA | BeFree | Detail | |
<0.001 | Non-Malignant Ascites Adverse Event | NA | BeFree | Detail | |
<0.001 | Chronic Kidney Diseases | NA | BeFree | Detail | |
0.002 | Fibrinogen Adverse Event | NA | GAD | Detail | |
<0.001 | tumor vasculature | NA | BeFree | Detail | |
<0.001 | Aggressive periodontitis, generalized | NA | BeFree | Detail | |
0.001 | Severe Sepsis | NA | BeFree | Detail | |
0.001 | Idiopathic Pulmonary Fibrosis | NA | BeFree | Detail | |
0.002 | ASPIRIN RESISTANCE | NA | GAD | Detail | |
<0.001 | Fibrinolytic Defect | NA | BeFree | Detail | |
<0.001 | THROMBOPHILIA DUE TO ACTIVATED PROTEIN C RESISTANCE (disorder) | NA | BeFree | Detail | |
0.012 | Venous thromboembolism | NA | GAD | Detail | |
0.001 | uterine corpus cancer | NA | BeFree | Detail | |
0.038 | coronary artery disease | NA | BeFree,GAD,LHGDN | Detail | |
0.005 | Precursor Cell Lymphoblastic Leukemia Lymphoma | NA | BeFree,GAD,LHGDN | Detail | |
0.011 | liver carcinoma | HIF-2alpha-dependent PAI-1 induction contributes to angiogenesis in hepatocellul... | BeFree,GAD,LHGDN | 25489981 | Detail |
<0.001 | Idiopathic Interstitial Pneumonias | NA | BeFree | Detail | |
<0.001 | Prothrombin G20210A mutation | NA | BeFree | Detail | |
<0.001 | Hereditary protein S deficiency | NA | BeFree | Detail | |
<0.001 | Allergic rhinitis (disorder) | NA | BeFree | Detail | |
0.001 | Thrombotic Microangiopathies | NA | BeFree | Detail | |
<0.001 | Infectious Otitis Media | NA | BeFree | Detail | |
0.002 | Infection of amniotic sac and membranes, unspecified, unspecified trimester, not applicable or unspecified | NA | GAD | Detail | |
0.002 | Recurrent pregnancy loss | NA | GAD | Detail | |
<0.001 | Obesity, Visceral | NA | BeFree | Detail | |
<0.001 | Plaque, Amyloid | In contrary, PAI-1 expression increases during aging or Aβ deposition with its c... | BeFree | 25454795 | Detail |
0.080 | Neointima | NA | RGD | Detail | |
<0.001 | Idiopathic pulmonary arterial hypertension | NA | BeFree | Detail | |
0.004 | Ischemic Cerebrovascular Accident | Plasminogen activator inhibitor-1 4G/5G polymorphism and ischemic stroke risk: a... | BeFree | 24472072 | Detail |
0.004 | Ischemic Cerebrovascular Accident | Global fibrinolytic activity, PAI-1 level, and 4G/5G polymorphism in Thai childr... | BeFree | 25284719 | Detail |
<0.001 | Homocysteinemia | NA | BeFree | Detail | |
<0.001 | Reflux nephropathy (disorder) | NA | BeFree | Detail | |
0.002 | granulomatosis with polyangiitis | NA | GAD | Detail | |
<0.001 | Allergic disposition | NA | BeFree | Detail | |
0.005 | Infection | NA | GAD | Detail | |
0.002 | Insulin resistance syndrome | NA | BeFree | Detail | |
0.008 | Spontaneous abortion | NA | GAD,LHGDN | Detail | |
0.005 | Abortion, Habitual | NA | GAD | Detail | |
<0.001 | acute pancreatitis | NA | BeFree | Detail | |
0.005 | adenocarcinoma | NA | BeFree,LHGDN | Detail | |
<0.001 | adenoma | NA | BeFree | Detail | |
<0.001 | Adenovirus Infections | NA | BeFree | Detail | |
<0.001 | Postoperative adhesion | NA | BeFree | Detail | |
0.002 | Albuminuria | NA | GAD | Detail | |
0.006 | Alzheimer's disease | Plasminogen activator inhibitor-1 as an early potential diagnostic marker for Al... | BeFree,GAD | 25304332 | Detail |
0.006 | Alzheimer's disease | Impacts of aging and amyloid-β deposition on plasminogen activators and plasmino... | BeFree,GAD | 25454795 | Detail |
0.003 | amyloidosis | NA | BeFree,GAD | Detail | |
0.005 | amyotrophic lateral sclerosis | NA | GAD | Detail | |
<0.001 | Anaplasia | NA | BeFree | Detail | |
0.005 | Anemia, Sickle Cell | NA | BeFree,GAD | Detail | |
0.003 | Aneurysm | NA | BeFree,GAD | Detail | |
0.003 | Angina Pectoris | NA | LHGDN | Detail | |
0.003 | Angina, Unstable | NA | BeFree,GAD | Detail | |
0.002 | Anoxia | NA | GAD | Detail | |
<0.001 | Anxiety Disorders | Using data from the borderline subscale of the Personality Assessment Inventory ... | BeFree | 23979607 | Detail |
0.081 | aortic aneurysm | NA | BeFree,RGD | Detail | |
0.008 | arteriosclerosis | NA | BeFree | Detail | |
<0.001 | arthritis | NA | BeFree | Detail | |
0.019 | rheumatoid arthritis | NA | BeFree,GAD,LHGDN | Detail | |
0.107 | asthma | NA | BeFree,GAD,LHGDN,RGD | Detail | |
<0.001 | Astrocytoma | NA | BeFree | Detail | |
0.145 | atherosclerosis | NA | BeFree,CTD_human,GAD,LHGDN | Detail | |
0.002 | atrial fibrillation | NA | GAD | Detail | |
0.120 | autistic disorder | NA | BeFree,CTD_human | Detail | |
0.002 | Bacteremia | NA | GAD | Detail | |
<0.001 | Bacterial Infections | NA | BeFree | Detail | |
0.125 | Behcet Syndrome | NA | BeFree,CTD_human,GAD | Detail | |
0.002 | beta thalassemia | NA | GAD | Detail | |
<0.001 | biliary atresia | NA | BeFree | Detail | |
<0.001 | Malignant neoplasm of urinary bladder | NA | BeFree | Detail | |
0.006 | Blood Coagulation Disorders | Using a murine model of severe TBI, we found that ICH is reduced in tPA(-/-) and... | BeFree,GAD | 25673638 | Detail |
<0.001 | borderline personality disorder | NA | BeFree | Detail | |
<0.001 | Brain Neoplasms | NA | BeFree | Detail | |
0.024 | Malignant neoplasm of breast | NA | BeFree,GAD | Detail | |
0.003 | bronchopulmonary dysplasia | NA | BeFree,GAD | Detail | |
0.001 | Malignant tumor of colon | The biologic consequences of PAI-1 silencing in colon cancer cell lines and CRC ... | BeFree | 26275833 | Detail |
0.001 | Malignant neoplasm of endometrium | NA | BeFree | Detail | |
<0.001 | Adenocarcinoma of prostate | NA | BeFree | Detail | |
<0.001 | Noninfiltrating Intraductal Carcinoma | NA | BeFree | Detail | |
<0.001 | Non-small cell lung carcinoma | NA | BeFree | Detail | |
0.001 | renal cell carcinoma | NA | BeFree | Detail |
Annotation
Annotations
Descrption | Source | Links |
---|---|---|
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
This review provides an overview on the current knowledge on PAI-1 especially importance of PAI-1 le... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Furthermore, unlike CEA and PAI-1, up-regulation of TRFM in pathological stages I & II groups compar... | DisGeNET | Detail |
Silencing of plasminogen activator inhibitor-1 suppresses colorectal cancer progression and liver me... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Our results show that plasma PAI-1 levels gradually increased as dementia progressed. | DisGeNET | Detail |
Using data from the borderline subscale of the Personality Assessment Inventory Borderline Features ... | DisGeNET | Detail |
Using data from the borderline subscale of the Personality Assessment Inventory Borderline Features ... | DisGeNET | Detail |
NA | DisGeNET | Detail |
Role of plasminogen activator inhibitor-1 in glucocorticoid-induced diabetes and osteopenia in mice. | DisGeNET | Detail |
Role of plasminogen activator inhibitor-1 in glucocorticoid-induced diabetes and osteopenia in mice. | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Patients with type 2 diabetes showed increased expression of PAI-1, indicative of reduced fibrinolys... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Association between plasminogen activator inhibitor-1 4G/5G gene polymorphism and immunoglobulin A n... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Penile pseudomyogenic hemangioendothelioma/epithelioid sarcoma-like hemangioendothelioma with a nove... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
In conclusion, thrombo and fibro-genetic mechanisms of PAI-1 4G-4G and MTHFR 677TT, could have a rol... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
PAI-1 polymorphism was synergistic with hyperinsulinemia. | DisGeNET | Detail |
PAI-1 deficiency significantly reduced insulin resistance and glucose intolerance but not hyperlipid... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Hypertension is associated with increased expression of FABP3, FAS, FN1, IL1R2, LPL, SERPINE1, TGFB1... | DisGeNET | Detail |
The presence of type 2 diabetes associated with 3.2-fold increased PAI-1 expression (adjusted p=0.03... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Plasminogen activator inhibitor-1 in cigarette smoke exposure and influenza A virus infection-induce... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Association of the plasminogen activator inhibitor-1 (PAI-1) Gene -675 4G/5G and -844 A/G promoter p... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
In conclusion, thrombo and fibro-genetic mechanisms of PAI-1 4G-4G and MTHFR 677TT, could have a rol... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
We found increased p53, PAI-1 and apoptosis in AECs, with accumulation of macrophages and neutrophil... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Plasma PAI-1 level was higher in CRC patients with liver metastasis and correlated with liver metast... | DisGeNET | Detail |
miR-30b may function as a novel tumor suppressor gene in gastric cancer by targeting PAI-1 and regul... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
In conclusion, the current study indicated that PAI-1 is involved in GC-induced glucose metabolism a... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Elevated levels of PAI-1 in MPN patients may result from its increased production by elevated number... | DisGeNET | Detail |
The association between plasminogen activator inhibitor type 1 (PAI-1) levels, PAI-1 4G/5G polymorph... | DisGeNET | Detail |
We aimed to investigate the association of plasminogen activator inhibitor-1 (PAI-1) and tissue plas... | DisGeNET | Detail |
PAI-1 plays a pivotal role in acute thrombotic events such as deep vein thrombosis (DVT) and myocard... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
The aim of this work was to establish an association between the single-nucleotide polymorphisms (SN... | DisGeNET | Detail |
The aim of this work was to establish an association between the single-nucleotide polymorphisms (SN... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Inhibition of plasminogen activator inhibitor-1 is a potential therapeutic strategy in ovarian cance... | DisGeNET | Detail |
P21, GADD45 and PAI-1 expression were down-regulated in mutant OCCs. | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
The 4G/4G polymorphism of the plasminogen activator inhibitor-1 (PAI-1) gene as an independent risk ... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
These observations indicate that increased PAI-1 expression promotes AEC apoptosis and exacerbates l... | DisGeNET | Detail |
NA | DisGeNET | Detail |
4G/5G polymorphism of plasminogen activator inhibitor-1 gene is associated with polycystic ovary syn... | DisGeNET | Detail |
Concentration of PAI-1:Ag was increased in patients with essential thrombocythemia and polycythemia ... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Hereditary hypofibrinolysis, which is mediated by 4G/4G homozygosity for the PAI-1 gene, is an indep... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
The biological effects of PAI-1 extend far beyond thrombosis including its critical role in fibrotic... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
In our study, the FII G20210A and the MTHFR C677T mutations resulted significantly higher in patient... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Expression levels of other TGF-β-regulated genes, including SERPINE1 and CTGF, declined (P = 0.049 a... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Pai-1 gene variants and COC use are associated with stroke risk: a case-control study in the Han Chi... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Concentration of PAI-1:Ag was increased in patients with essential thrombocythemia and polycythemia ... | DisGeNET | Detail |
Association between the plasminogen activator inhibitor-1 4G/5G polymorphism and risk of venous thro... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
ATM activation (pATM(Ser1981)) increased 4-fold in the tubulointerstitial region of the unilateral u... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
The inactivation of plasminogen activator inhibitor-1 (PAI-1) has been shown to exert beneficial eff... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Plasminogen activator inhibitor-1 in cigarette smoke exposure and influenza A virus infection-induce... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
PAI-1 4G/5G and MTHFR C677T polymorphisms increased the accuracy of two prediction scores for the ri... | DisGeNET | Detail |
PAI-1 plays a pivotal role in acute thrombotic events such as deep vein thrombosis (DVT) and myocard... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Relation of PAI-1 and TPA genes polymorphisms to acute myocardial infarction and its outcomes in Egy... | DisGeNET | Detail |
NA | DisGeNET | Detail |
In conclusion, thrombo and fibro-genetic mechanisms of PAI-1 4G-4G and MTHFR 677TT, could have a rol... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
MiR-10a and miR-181c regulate collagen type I generation in hypertrophic scars by targeting PAI-1 an... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Although FOSB-rearranged EH do not show significant morphologic overlap with SERPINE1-FOSB fusion-po... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Interestingly, expression of PAI-1 was increased in ovarian clear cell carcinoma compared with that ... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Plasminogen activator inhibitor-1 and susceptibility to lung cancer: a population genetics perspecti... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
PAI-1 deficiency significantly reduced insulin resistance and glucose intolerance but not hyperlipid... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
In contrary, PAI-1 expression increases during aging or Aβ deposition with its clusters surrounding ... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
PAI-1 4G/5G and MTHFR C677T polymorphisms increased the accuracy of two prediction scores for the ri... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Animal models of non-alcoholic fatty liver disease (NAFLD) suggest that an increased translocation o... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Silencing of plasminogen activator inhibitor-1 suppresses colorectal cancer progression and liver me... | DisGeNET | Detail |
Our results show that plasma PAI-1 levels gradually increased as dementia progressed. | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
The current study tried to investigate in parallel the association of PAI-1 activity with the PAI-1 ... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
The polymorphisms of FVL and FII should be screened in RM women, whereas PAI-1 seems to be weakly as... | DisGeNET | Detail |
In terms of subgroup analyses on co-existence of other thrombotic risk factors, the PAI-1 4G/5G poly... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
P21, GADD45 and PAI-1 expression were down-regulated in mutant OCCs. | DisGeNET | Detail |
NA | DisGeNET | Detail |
Plasminogen activator inhibitor-1 and susceptibility to lung cancer: a population genetics perspecti... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
The biologic consequences of PAI-1 silencing in colon cancer cell lines and CRC bearing nude mice we... | DisGeNET | Detail |
miR-30b may function as a novel tumor suppressor gene in gastric cancer by targeting PAI-1 and regul... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
The prevalence of 4G/5G polymorphism of plasminogen activator inhibitor-1 (PAI-1) gene in central se... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
In an attempt to treat EAMG with an 18aa peptide derived from the PA system inhibitor (PAI-1), desig... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Plasminogen activator inhibitor-1 4G/5G polymorphism and ischemic stroke risk: a meta-analysis in Ch... | DisGeNET | Detail |
Global fibrinolytic activity, PAI-1 level, and 4G/5G polymorphism in Thai children with arterial isc... | DisGeNET | Detail |
Healthy HDL inhibited thrombin-induced plasminogen activator inhibitor type 1 (PAI-1) expression, wh... | DisGeNET | Detail |
The -844 G>A PAI-1 polymorphism is associated with acute coronary syndrome in Mexican population. | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Inhibition of plasminogen activator inhibitor-1 is a potential therapeutic strategy in ovarian cance... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
The mean levels of plasma PAI-1 in patients with MCI and AD patients were significantly higher than ... | DisGeNET | Detail |
Three hundred and fifty six patients with first myocardial infarction (MI) were followed up during a... | DisGeNET | Detail |
NA | DisGeNET | Detail |
Elevated levels of PAI-1 in MPN patients may result from its increased production by elevated number... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
We conclude that the HIF-2α target gene PAI-1 favors the angiogenic switch in HCC. | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Furthermore, unlike CEA and PAI-1, up-regulation of TRFM in pathological stages I & II groups compar... | DisGeNET | Detail |
Silencing of plasminogen activator inhibitor-1 suppresses colorectal cancer progression and liver me... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
HIF-2alpha-dependent PAI-1 induction contributes to angiogenesis in hepatocellular carcinoma. | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
In contrary, PAI-1 expression increases during aging or Aβ deposition with its clusters surrounding ... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Plasminogen activator inhibitor-1 4G/5G polymorphism and ischemic stroke risk: a meta-analysis in Ch... | DisGeNET | Detail |
Global fibrinolytic activity, PAI-1 level, and 4G/5G polymorphism in Thai children with arterial isc... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Plasminogen activator inhibitor-1 as an early potential diagnostic marker for Alzheimer's disease. | DisGeNET | Detail |
Impacts of aging and amyloid-β deposition on plasminogen activators and plasminogen activator inhibi... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Using data from the borderline subscale of the Personality Assessment Inventory Borderline Features ... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Using a murine model of severe TBI, we found that ICH is reduced in tPA(-/-) and uPA(-/-) mice but i... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
The biologic consequences of PAI-1 silencing in colon cancer cell lines and CRC bearing nude mice we... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Overlapped Transcript Coordinates
Gene | Transcript ID | Exon Number | Chromosome | Start | Stop | Type | Amino Mutation | Transcript Position | Links |
---|
Overlapped Transcript
Gene | Transcript ID | Chromosome | Start | Stop | Links |
---|
- Gene
- -
- dbSNP
- rs17886084 dbSNP
- Genome
- hg19
- Position
- chr7:100,770,385-100,782,528
- Variant Type
- snv
Genome browser